stars 1 stars 2 stars 3

CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. In July 2020, CureVac entered in a collaboration with GSK to jointly develop new products in prophylactic vaccines for infectious diseases based on CureVac’s second-generation mRNA technology. This collaboration was later extended to the development of second-generation COVID-19 vaccine candidates, and modified mRNA vaccine technologies. Based on its proprietary technology, CureVac has built a deep clinical pipeline across the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. CureVac N.V. has its headquarters in Tübingen, Germany, and has more than 1,100 employees across its sites in Germany, the Netherlands, Belgium, Switzerland and the U.S. Further information can be found at

View Top Employees from CureVac
Revenue $91 million
Funding $1.8 billion
Employees 846 (631 on RocketReach)
Founded 2000
Address Friedrich-Miescher-Str. 15, Tübingen, Baden-Württemberg 72076, DE
Phone +49 7071 98830
JavaScript, HTML, PHP +45 more (view full list)
Category Biotechnology, Biotechnology Research, Manufacturing General, Biopharma, Drug Discovery, Manufacturing, Health Care, Science and Engineering, Therapeutics
Web Rank 1 Million
Keywords curevac, curevac jobs, curevac wistar, curevac ag, curevac cv8102
Competitors Acceleron Pharma, BioNTech SE, Dynavax Technologies, Immatics, MacroGenics, Inc.
SIC SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies

CureVac Questions

The CureVac annual revenue was $91 million in 2024.

Alexander Zehnder is the CEO of CureVac.

631 people are employed at CureVac.

CureVac is based in Tübingen, Baden-Württemberg.

The NAICS codes for CureVac are [3254, 325, 32541, 32].

The SIC codes for CureVac are [80, 283, 28].

Top CureVac Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users